Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Iron Chelation”

81 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 81 results

Testing effectiveness (Phase 2)Study completedNCT00940602
What this trial is testing

Myelodysplastic Syndromes (MDS) Event Free Survival With Iron Chelation Therapy Study

Who this might be right for
Myelodysplastic Syndromes
Novartis Pharmaceuticals 225
Post-approval studies (Phase 4)Ended earlyNCT02041299
What this trial is testing

Efficacy and Safety of Ferriprox® in Patients With Sickle Cell Disease or Other Anemias

Who this might be right for
Iron OverloadSickle Cell DiseaseOther Anemias
ApoPharma 230
Post-approval studies (Phase 4)Study completedNCT03591575
What this trial is testing

Safety and Efficacy of Early Treatment With Deferiprone in Infants and Young Children

Who this might be right for
Beta Thalassemia Major AnemiaIron Overload
Chiesi Canada Corp 64
Testing effectiveness (Phase 2)Study completedNCT00379483
What this trial is testing

Extension Study of Iron Chelation Therapy With Deferasirox in Patients With Transfusional Iron Overload

Who this might be right for
Transfusional Iron Overload
Novartis Pharmaceuticals 66
Testing effectiveness (Phase 2)Looking for participantsNCT07236463
What this trial is testing

Labile Iron Removal by Adding the Iron Chelator MEX-CD1 to Dialysate in Sepsis-Associated Acute Kidney Injury

Who this might be right for
Acute Kidney InjurySepsis
Centre Hospitalier Universitaire de Nīmes 14
Testing effectiveness (Phase 2)Study completedNCT00390858
What this trial is testing

A 4-year Extension Study to Core 1-year Study of Iron Chelation Therapy With Deferasirox in β-thalassemia Major Pediatric Patients With Transfusional Iron Overload.

Who this might be right for
Transfusional Iron Overloadβ-thalassemia MajorPediatric Rare Anemia
Novartis Pharmaceuticals 40
Early research (Phase 1)Study completedNCT00004982
What this trial is testing

Combination Iron Chelation Therapy

Who this might be right for
Iron OverloadThalassemia
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Testing effectiveness (Phase 2)Study completedNCT01709032
What this trial is testing

Combination Deferasirox and Deferiprone for Severe Iron Overload in Thalassemia

Who this might be right for
Thalassemia Major With Severe Transfusional Iron Overload
Children's Hospital of Philadelphia 9
Early research (Phase 1)Ended earlyNCT02274233
What this trial is testing

Safety and Pharmacokinetic Study of Escalating Doses of SP-420, an Iron Chelator, in Patients With β-Thalassemia

Who this might be right for
Iron OverloadBeta-Thalassemia
Sideris Pharmaceuticals 24
Post-approval studies (Phase 4)Study completedNCT00105495
What this trial is testing

Efficacy Study in Removing Excess Iron From the Heart

Who this might be right for
Thalassemia MajorHemosiderosis
ApoPharma 60
Testing effectiveness (Phase 2)Study completedNCT03637556
What this trial is testing

Pilot Study to Assess the Safety, PK and Iron Chelating Activity of DST-0509 (Deferasirox) in Thalassemia Patients Refractory to Chelation

Who this might be right for
Thalassemia Major
DisperSol Technologies, LLC 25
Post-approval studies (Phase 4)UnknownNCT00103753
What this trial is testing

Combined Chelation Treatment With Deferiprone and Deferoxamine in Thalassemia Major

Who this might be right for
Beta-Thalassemia
Royal Brompton & Harefield NHS Foundation Trust 65
Large-scale testing (Phase 3)Study completedNCT02720536
What this trial is testing

Extended Evaluation of Deferasirox Film-coated Tablet (FCT) Formulation

Who this might be right for
Chronic Iron Overload
Novartis Pharmaceuticals 53
Not applicableStudy completedNCT04435028
What this trial is testing

Ketotifen: as a Cardioprotective Agent in Breast Cancer Patients Receiving Anthracycline-containing Chemotherapy

Who this might be right for
Breast CancerIron Chelation
Horus University 111
Testing effectiveness (Phase 2)Study completedNCT00901199
What this trial is testing

Combined Chelation Therapy in Patients With Transfusion Dependent Thalassemia and Iron Overload

Who this might be right for
ThalassemiaIron Overload
Elliott Vichinsky 22
Not applicableStudy completedNCT01394029
What this trial is testing

Observation of Patients With Transfusional Hemosiderosis Treatment With Deferasirox

Who this might be right for
Transfusional Hemosiderosis
Novartis Pharmaceuticals 120
Large-scale testing (Phase 3)Study completedNCT00171210
What this trial is testing

An Extension Study of Iron Chelation Therapy With Deferasirox (ICL670) in β-thalassemia Patients With Transfusional Iron Overload

Who this might be right for
Transfusional Iron Overload in β-thalassemia
Novartis Pharmaceuticals 506
Testing effectiveness (Phase 2)Study completedNCT01539837
What this trial is testing

A Pilot Clinical Trial With the Iron Chelator Deferiprone in Parkinson's Disease

Who this might be right for
Parkinson's Disease
Imperial College London 22
Large-scale testing (Phase 3)UnknownNCT02083575
What this trial is testing

Role of Vitamin C to Augment Iron Chelation With DFP or DFX

Who this might be right for
Vitamin cThalassemia MajorIron Chelation
Ain Shams University 50
Large-scale testing (Phase 3)Study completedNCT02065492
What this trial is testing

Amlodipine for Myocardial Iron in Thalassemia

Who this might be right for
Thalassemia
Aga Khan University 20
Next Page